Our research
Learn about our research and our research projects here
ALS (amyotrophic lateral sclerosis) is a fatal neuromuscular disease that is characterized by a degeneration of upper and lower motorneurons. The patients experience a weakness usually starting in the upper or lower extremities spreading to other regions weakening both speech and swallowing. Besides the muscle weakness, cognitive dysfunction and behavioral changes are seen in about 50% of the patients and some develop fulminant frontotemporal dementia.
Learn about our research and our research projects here
ALS Clinical Research Group´s webpage.
The group strives to integrate ALS research and care by conducting clinical research.
Take some time to listen to three new ALS related radio interviews, from April 23th 2024.
1. Sofia Imrell talks us through her recent research on the latest ALS numbers in Sweden.
2. The recent work from our team was discussed on the Radio as Tomas Hedman presented results showing an increase in the number of ALS cases, specifically in Sweden.
3. Caroline Ingre elaborate on the importance of more ALS research in Sweden.
On March 20, Caroline Ingre received a grant from the Royal foundation, supporting and acknowledging ALS research conducted in Sweden.
Neuroförbundet distributes close to SEK 14 million to three ALS research projects. The research should contribute to better nursing, new medicines and precision medicines.
Title: Biomarkers and psychological stress in amyotrophic lateral sclerosis